Inventor
FU JIAN-MIN
US40 patents
⚠️ This page may combine multiple inventors who share the name “FU JIAN-MIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PFIZER
11 patentsUS6992087B2Jan 31, 2006
Substituted aryl 1,4-pyrazine derivatives
PFIZER68 citations97
US7041672B2May 9, 2006
Substituted aryl 1, 4-pyrazine derivatives
PFIZER59 citations95
US6828314B2Dec 7, 2004
Substituted azepino[4,5b]indoline derivatives
PFIZER38 citations95
US6903090B2Jun 7, 2005
Substituted azepino[4,5b]indole derivatives
PFIZER5 citations72
US7034023B2Apr 25, 2006
Pyrrolo[1,2-B]pyridazine compounds and their uses
PFIZER3 citations63
US7087617B2Aug 8, 2006
Substituted pyrimidine derivatives
PFIZER6 citations62
US7015229B2Mar 21, 2006
Substituted pyrimidinones and pyrimidinthiones
PFIZER3 citations62
US7074791B2Jul 11, 2006
Pyrrolo[1,2-b]pyridazine compounds and their uses
PFIZER1 citations52
US7056920B2Jun 6, 2006
Pyrrolo[1,2-B]pyridazine compounds and their uses
PFIZER1 citations52
US7041671B2May 9, 2006
Pyrrolo[1,2-b]pyridazine compounds and their uses
PFIZER1 citations52
US7250418B2Jul 31, 2007
Compounds as CRF1 receptor antagonists
PFIZER0 citations41
UPJOHN CO
11 patentsUS6849640B2Feb 1, 2005
Therapeutic 1H-pyrido [4,3-b] indoles
UPJOHN CO113 citations97
US6586421B2Jul 1, 2003
Substituted azepino[4,5b]indoline derivatives
UPJOHN CO5 citations72
US6887868B2May 3, 2005
Therapeutic 5-HT ligand compounds
UPJOHN CO6 citations63
US6503899B2Jan 7, 2003
Azepino[4,5-b]pyrano[3,2-e]indoles
UPJOHN CO4 citations63
US6583135B2Jun 24, 2003
Substituted azepino[4,5b]indole derivatives
UPJOHN CO1 citations60
US7291738B2Nov 6, 2007
Therapeutic compounds
UPJOHN CO1 citations52
US6930105B2Aug 16, 2005
Tetracyclicazaindoles and indolines having 5-HT activity
UPJOHN CO1 citations52
US6727274B2Apr 27, 2004
Arylsulphonyl substituted-tetrahydro- and hexahydro-carbazoles
UPJOHN CO1 citations52
US6861420B2Mar 1, 2005
N-substituted 1,2,4,5-tetrahydro-1H-benzo[d]azepine compounds
UPJOHN CO0 citations42
US6565829B2May 20, 2003
5-arylsulfonyl indoles useful for treating disease
UPJOHN CO0 citations42
US7022694B2Apr 4, 2006
Indoles and indolines having 5-HT activity
UPJOHN CO0 citations34
ALLELIX BIOPHARMA
11 patentsUS5834459ANov 10, 1998
Alkyl-substituted compounds having dopamine receptor affinity
ALLELIX BIOPHARMA21 citations92
US5700445ADec 23, 1997
N-methyl piperazine compounds having dopamine receptor affinity
ALLELIX BIOPHARMA24 citations92
US5602124AFeb 11, 1997
5-HT2 receptor ligands
ALLELIX BIOPHARMA28 citations92
US5602121AFeb 11, 1997
Alkyl-substituted compounds having dopamine receptor affinity
ALLELIX BIOPHARMA23 citations92
US5602120AFeb 11, 1997
Benzyl-substituted compounds having dopamine receptor affinity
ALLELIX BIOPHARMA18 citations92
US5538965AJul 23, 1996
Dopamine receptor ligands
ALLELIX BIOPHARMA20 citations92
US5968478AOct 19, 1999
N- methyl piperazine compounds having dopamine receptor affinity
ALLELIX BIOPHARMA16 citations82
US5824676AOct 20, 1998
5-HT2 receptor ligands
ALLELIX BIOPHARMA7 citations74
US5814628ASep 29, 1998
Benzyl-substituted compounds having dopamine receptor affinity
ALLELIX BIOPHARMA15 citations73
US6103715AAug 15, 2000
Dopamine receptor ligands
ALLELIX BIOPHARMA3 citations63
US5798350AAug 25, 1998
Dopamine receptor ligands
ALLELIX BIOPHARMA4 citations63
XENON PHARMACEUTICALS INC
3 patentsUS7335658B2Feb 26, 2008
Pyridazine derivatives and their use as therapeutic agents
XENON PHARMACEUTICALS INC59 citations97
US7919484B2Apr 5, 2011
Combination therapy
XENON PHARMACEUTICALS INC10 citations83
US7754711B2Jul 13, 2010
Pyridazine derivatives and their use as therapeutic agents
XENON PHARMACEUTICALS INC2 citations62